Advertisement

Topics

Zylepsis Limited Company Profile

15:37 EST 23rd November 2017 | BioPortfolio

Our value is our unrivalled ability to enable almost limitless supplies of natural bioingredients to be produced with no harmful chemicals or genetic modification. To achieve this we have developed proprietary process technologies, including biotransformation and unique separation techniques, suitable for a wide range of applications. In essence, biotransformation uses natural microorganisms and enzymes to convert a starting material into a more useful and valuable compound. Zylepsis has built an extensive library of organisms (and enzymes) that work under mild conditions, usually in water, at non-extreme temperatures. They do not use toxic chemical reagents, nor do they leave harmful residues for disposal. In addition to these already considerable advantages, biotransformation often allows complex or unusual reactions to be performed, not possible using conventional chemistry. We are able to exploit the selectivity and specificity of enzymes and organisms to control the biocatalytic process that will produce the desired ingredient.

Location

6 Highpont, Henwood Business Estate
Ashford
Kent
TN24 8DH
United Kingdom

Contact

Phone: 01233 660 555
Fax: 01233 660 777
Email: info@zylepsis.co.uk


News Articles [19 Associated News Articles listed on BioPortfolio]

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering

MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagn...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [82 Associated Companies listed on BioPortfolio]

Zylepsis Limited

Our value is our unrivalled ability to enable almost limitless supplies of natural bioingredients to be produced with no harmful chemicals or genetic modification. To achieve this we have developed pr...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Zylepsis Limited" on BioPortfolio

We have published hundreds of Zylepsis Limited news stories on BioPortfolio along with dozens of Zylepsis Limited Clinical Trials and PubMed Articles about Zylepsis Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zylepsis Limited Companies in our database. You can also find out about relevant Zylepsis Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record